World Down Syndrome Day 2026: Together Against Loneliness

Observed annually on 21 March, World Down Syndrome Day (WDSD) is a global awareness day dedicated to recognising the rights, achievements, and contributions of people with Down’s syndrome.

The date itself carries meaning, with 21/3 representing the triplication of chromosome 21 – the genetic cause of Down’s syndrome.

This year’s theme, Together Against Loneliness, shines a light on one of the most significant but often overlooked challenges facing people with Down’s syndrome and other intellectual disabilities: the experience of loneliness and social exclusion.

The theme is a call to action for individuals, families, communities, employers, and governments to take meaningful steps towards real inclusion.

Ways to mark WDSD this year include joining the #LotsOfSocks campaign by wearing bright, mismatched socks on 21 March to spark conversations about Down’s syndrome and sharing messages of support on social media using the hashtags #WorldDownSyndromeDay and #TogetherAgainstLoneliness.

What is Down’s syndrome?

Down’s syndrome, also known as Down syndrome, is a genetic condition and one of the most common chromosomal conditions worldwide.

It occurs when a person is born with an extra copy of chromosome 21, which affects the way the brain and body develop, and it is estimated that there are around 47,000 people living in the UK who have Down’s syndrome.

Every person with Down’s syndrome is unique, with their own personality, strengths, and abilities. However, some common characteristics associated with the condition include:

• Physical features such as almond-shaped eyes, a single crease across the palm, and a slightly flattened facial profile
• Mild to moderate intellectual disability, which can affect learning and communication in different ways
• An increased likelihood of certain medical conditions, such as congenital heart defects, low muscle tone, and thyroid disorders

While some aspects of Down’s syndrome can have an impact on a person’s physical health, advances in medical care and greater social inclusion have significantly improved both life expectancy and quality of life.

Many people with Down’s syndrome lead healthy, fulfilling lives, attending school, working, forming relationships, and making valuable contributions to their communities.

Learn more: What is Down’s syndrome?

The three types of Down’s syndrome

There are three types of Down’s syndrome, all caused by the presence of extra genetic material from chromosome 21.

While the characteristics of each type are broadly similar, the way in which the extra chromosome is present in the cells differs.

1. Trisomy 21 (95% of cases)

The most common form of Down’s syndrome, Trisomy 21 occurs when every cell in the body contains a full extra copy of chromosome 21. This happens because of a random error in cell division during early development.

2. Mosaic Down’s syndrome (2% of cases)

A rarer form of the condition, Mosaic Down’s syndrome occurs when only some cells carry an extra chromosome 21, while others have the usual 46 chromosomes.

This happens due to an error in cell division after fertilisation, resulting in a mix – or mosaic – of normal and trisomic cells. People with Mosaic Down’s syndrome may experience fewer characteristics associated with the condition, depending on the proportion of cells affected.

3. Translocation Down’s syndrome (3% of cases)

Translocation Down’s syndrome occurs when an extra copy of part or all of chromosome 21 attaches, or translocates, to another chromosome rather than existing as a separate copy.

Unlike the other types, this form can in some cases be inherited if a parent carries a balanced translocation, although the majority of cases occur spontaneously.

While Down’s syndrome is not typically hereditary, around 1% of cases have a genetic link, particularly in translocation Down’s syndrome.

Together Against Loneliness: why this theme matters

For many people, loneliness is a fleeting experience. For people with Down’s syndrome and other intellectual disabilities, it can be a far more frequent reality.

Research highlights the scale of the problem:

• 39% of people with intellectual disabilities often feel lonely, compared to 14% of people without disabilities (Bishop, Llewellyn and Kavanagh, Australia, 2024)
• People with an intellectual disability are seven times more likely to be lonely than the general public (Mencap, UK, 2019)
• Loneliness can be as harmful to health as smoking 15 cigarettes a day, contributing to anxiety, depression, and physical health problems

Crucially, loneliness is not a choice. It happens when people are not supported to build and maintain connections with others, and is driven by stigma, discrimination, and exclusion from schools, workplaces, and community life.

Families can also feel the impact, with many parents and carers experiencing their own sense of isolation when access to support is limited.

Genetic screening for Down’s syndrome

For many expectant parents, the prospect of a Down’s syndrome diagnosis raises important questions about the options available for screening and testing during pregnancy.

NHS screening for Down’s syndrome

The NHS offers screening tests for Down’s syndrome as part of routine antenatal care. The two main options are:

• The combined test – available between 10 and 14 weeks of pregnancy, this includes a blood test and an ultrasound scan (nuchal translucency measurement). It provides a risk estimate for Down’s syndrome, Edward’s syndrome, and Patau’s syndrome, rather than a definitive diagnosis.
• The quadruple blood screening test – available between 14 and 20 weeks, this screens for Down’s syndrome only and is offered where the combined test was not possible.

It’s important to note that NHS screening tests are only offered to women deemed at higher risk, based on factors such as maternal age and weight.

If a screening test indicates high risk, further diagnostic tests such as amniocentesis or chorionic villus sampling (CVS) may be offered, but these carry a small risk of miscarriage.

Private Non-Invasive Prenatal Genetic Testing (NIPT)

Because NHS screening tests are often carried out over several weeks throughout the first and/or second trimesters of pregnancy, some expectant parents may wish to pay for a private test, so that they can find out more quickly whether their pregnancy is high risk.

An AlphaBiolabs Non-Invasive Prenatal Genetic Testing (NIPT) is ideally suited for this purpose.

All the test requires is a blood sample from the mother, which can be collected from as early as 10 weeks into pregnancy and is available to anyone, not just expectant mothers who have been designated high risk.

Our non-invasive prenatal tests (NIPTs) – Standard, Advanced and Premium – can detect 97.2%-100% of trisomies in single and twin pregnancies.

They can also be used to determine the sex of the baby while the mother is still pregnant, something which is not offered by the NHS.

Additionally, the results of our NIPTs are available in only 5 business days, meaning that you will receive your results much faster than if you were to follow the traditional NHS pathway.

For more information about this test, call our friendly, knowledgeable and discreet Customer Services team on 0333 600 1300 or email info@alphabiolabs.com.

You can also visit our Learning Centre to find out more about non-invasive prenatal testing.